Dicot Pharma Management
Management criteria checks 3/4
Dicot Pharma's CEO is Elin Trampe, appointed in Apr 2022, has a tenure of 3.08 years. total yearly compensation is SEK2.16M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.033% of the company’s shares, worth €34.19K. The average tenure of the management team and the board of directors is 2.8 years and 4 years respectively.
Key information
Elin Trampe
Chief executive officer
SEK 2.2m
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 3.1yrs |
| CEO ownership | 0.03% |
| Management average tenure | 2.8yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -SEK 67m |
| Dec 31 2024 | SEK 2m | SEK 2m | -SEK 58m |
| Sep 30 2024 | n/a | n/a | -SEK 53m |
| Jun 30 2024 | n/a | n/a | -SEK 51m |
| Mar 31 2024 | n/a | n/a | -SEK 48m |
| Dec 31 2023 | SEK 2m | SEK 2m | -SEK 44m |
| Sep 30 2023 | n/a | n/a | -SEK 37m |
| Jun 30 2023 | n/a | n/a | -SEK 34m |
| Mar 31 2023 | n/a | n/a | -SEK 32m |
| Dec 31 2022 | SEK 1m | SEK 1m | -SEK 32m |
Compensation vs Market: Elin's total compensation ($USD224.82K) is below average for companies of similar size in the German market ($USD505.85K).
Compensation vs Earnings: Elin's compensation has increased whilst the company is unprofitable.
CEO
Elin Trampe (44 yo)
Ms. Elin Trampe serves as Chief Executive Officer at Dicot Pharma AB (formerly known as Dicot AB (publ)) since April 1, 2022. She served as Vice President for Dicot Pharma AB (formerly known as Dicot AB (p...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 3.1yrs | SEK 2.16m | 0.033% € 34.2k | |
| Founder | no data | SEK 67.75k | no data | |
| Chief Financial Officer | 3.2yrs | no data | no data | |
| Chief Technical Officer | 1.8yrs | no data | no data | |
| Chief Scientific Officer | 2.8yrs | no data | 0.015% € 15.8k | |
| Chief Business Officer | less than a year | no data | no data |
Experienced Management: KN0's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 2yrs | SEK 75.00k | no data | |
| Independent Director | 3.1yrs | SEK 75.00k | no data | |
| Independent Director | 4yrs | SEK 125.00k | 0.030% € 31.3k | |
| Independent Chairman of the Board | 4.5yrs | SEK 170.00k | 0.041% € 43.0k | |
| Independent Director | 7.3yrs | SEK 75.00k | no data |
Experienced Board: KN0's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 14:38 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dicot Pharma AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.